Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where therapy selections remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline We https://financefeeds.com/ion-markets-joins-pasla-to-enhance-securities-lending-in-apac/